Agomab Therapeutics (Series D)
Funding Details
- Date Award
- June 09, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $89,000,000
Company Info
- Founding Year
- 2015
- Traction
- Raised $89 million in Series D funding.
- Company Description
- Agomab Therapeutics is a biotechnology company that develops treatments targeting fibrotic diseases, focusing on conditions like fibrostenosing Crohn’s disease and idiopathic pulmonary fibrosis.
- Market
- Healthcare
- Location
- Antwerp, Belgium
- Coinvestors
- Sanofi, Invus